Solid tumor immunotherapy using NKG2D-based adaptor CAR T cells.
Obajdin J, Larcombe-Young D, Glover M, Kausar F, Hull CM, Flaherty KR, Tan G, Beatson RE, Dunbar P, Mazza R, Bove C, Taylor C, Bille A, Spillane KM, Cozzetto D, Vigilante A, Schurich A, Davies DM, Maher J.
Obajdin J, et al. Among authors: bove c.
Cell Rep Med. 2024 Nov 19;5(11):101827. doi: 10.1016/j.xcrm.2024.101827.
Cell Rep Med. 2024.
PMID: 39566469